Single enzyme biomarker hailed as memory key despite n=13 human sample; structural determinants of cognitive aging erased
Original framing: “Memory stays strong in old age when this brain enzyme is active” — Nature
Indigenous neuroscience frameworks (e.g., Māori 'te whare tapa whā', Native American 'medicine wheel') conceptualize cognitive health as balance across spiritual, mental, physical, and familial dimensions — ABHD12 levels would be seen as one thread in a woven mat, not the mat itself. Elders in these systems maintain memory through ceremonial repetition, land-based navigation, and language transmission, practices that engage distributed neural networks far beyond lipid metabolism. The enzyme narrative extracts a molecule from its cultural ecology, committing what Linda Tuhiwai Smith calls 'research imperialism'.
The ABHD12 finding is a real molecular correlation — but Nature's framing performs a sleight of hand: it presents a biomarker as a breakthrough while burying the 13-brain sample, the mouse-human chasm, and the 40-year graveyard of similar 'key enzyme' claims.
Power operates through omission: by erasing the Tsimane elder with 70% less atrophy, the Guatemalan campesina navigating milpa and memory, the Black American elder poisoned by lead pipes, the story protects the pharmaceutical pipeline from the uncomfortable truth that cognitive resilience is politically produced. The trickster sees the joke: we hunt for memory's molecule in 13 frozen brains while the living elders who hold memory — in stories, songs, landscapes, languages — are displaced, poisoned, and ignored. A systemic correction doesn't deny the enzyme; it situates it within the exposome, the community, the history, and the justice question: who gets to age with their mind intact, and who decides what 'intact' means?